Tanja Rudolph

Tanja Rudolph

Interventional cardiologist / Cardiologist
Heart and Diabetes Center NRW - Bad Oeynhausen, Germany

Latest contributions

How to approach the challenges of large annuli in TAVI

29 Aug 2025

Register for free to this webinar on Monday 8 September at 5:00pm (UTC+2) with T. Rudolph, D. Buckert and A. Schäfer and understand the challenges of TAVI in patients with large annuli, and much more!

Valve choice - Shaping index procedures and lifetime patient management

22 May 2025 – From EuroPCR 2025

This session addresses recent advancements and ongoing challenges in transcatheter aortic valve implantation (TAVI), with a particular focus on valve selection during index procedures. Presentations include data from the Accurate IDE trial, highlighting the prognostic implications of valve underexpansion. A clinical case involving an 80-year-old patient with severe...

Valve choice - Shaping index procedures and lifetime patient management

Redo TAVI - How to treat different TAVI platforms when they fail

22 May 2025 – From EuroPCR 2025

Understand the complexities of redo TAVI procedures with emphasis on planning, valve platform characteristics, and tailored procedural strategies. This session features cases of redo TAVI for failed short-frame and tall-frame valves, alongside discussions on current evidence gaps guiding optimal management.

Redo TAVI - How to treat different TAVI platforms when they fail

What did we learn from my TAVI complications?

22 May 2025 – From EuroPCR 2025

Review critical lessons from TAVI complications, focusing on early identification and management of access site issues and acute coronary obstruction. Learn effective preventive actions and procedural strategies to minimize severe TAVI-related complications through detailed case discussions.

What did we learn from my TAVI complications?

TAVI in difficult scenarios: bicuspid anatomy and pure aortic regurgitation

22 May 2025 – From EuroPCR 2025

Address challenging TAVI scenarios involving bicuspid anatomy and pure aortic regurgitation with insights from international experiences. This session compares treatment options in China and Germany, explores anatomical and disease differences, and reviews various TAVI devices through detailed case presentations and expert commentary.

TAVI in difficult scenarios: bicuspid anatomy and pure aortic regurgitation

Hotline TAVI 3: Challenging anatomical and clinical scenarios

22 May 2025 – From EuroPCR 2025

This hotline session presents challenging anatomical and clinical scenarios in TAVI, including outcomes in bicuspid aortic valve patients, chronic aortic regurgigation, comparisons of surgical versus percutaneous approaches, and real-world data on valve performance and resource utilization.

Inludes:

  • Five-year outcomes from the Evolut low risk TAVR bicuspid study
  • Surgical versus...
Hotline TAVI 3: Challenging anatomical and clinical scenarios

Novel devices for edge-to-edge mitral repair

21 May 2025 – From EuroPCR 2025

Discover novel devices advancing transcatheter edge-to-edge mitral valve repair (TEER). This session presents clinical experiences with cost-effective and uniquely designed TEER systems for patients with degenerative mitral regurgitation and heart failure, including first-in-man applications and case series demonstrating safety and efficacy.

Novel devices for edge-to-edge mitral repair

Hotline TAVI 1: extended analysis of the randomised trials

21 May 2025 – From EuroPCR 2025

Gain comprehensive insights from extended analyses of randomized TAVI trials. This session reviews five-year UK TAVI outcomes, cardiac damage evolution in asymptomatic aortic stenosis, one-year results from the LANDMARK trial, and three-year comparisons of balloon-expandable valves, highlighting critical clinical implications.

Hotline TAVI 1: extended analysis of the randomised trials

Full physiology: why and how to assess beyond coronary epicardial disease

20 May 2025 – From EuroPCR 2025

Understanding full coronary physiology is key to improving patient care. This EuroPCR 2025 session unpacks the concept and shows how to apply it easily in everyday clinical settings. Explore the latest ESC guidelines for managing patients with angina and no obstructive coronary artery disease (ANOCA), supported...

Full physiology: why and how to assess beyond coronary epicardial disease

Redo TAVI: how to treat different TAVI platforms when they fail?

22 May 2025 – From EuroPCR 2025

In this EuroPCR 2025 interview, Tanja Rudolph, Dan Blackman, and Radoslaw Parma take a deep dive into the current understanding of redo TAVR.

Together, they address the main challenges faced in repeat procedures—chiefly, the risk of coronary obstruction and the importance of preserving coronary access, alongside strategies...

Redo TAVI: how to treat different TAVI platforms when they fail?

Expanding the heart team - Improved TAVI outcomes through pre-and post-procedure collaboration

16 May 2024 – From EuroPCR 2024

In this session, learn how to advance heart team collaboration through optimized TAVI pre-work-up and refined severe aortic stenosis patient selection, ensuring accurate intervention indications. Gain hands-on insights for effective post-TAVI strategies, explore procedural and valve refinements that simplify post-TAVI PCI, and stay informed on the...

Expanding the heart team - Improved TAVI outcomes through pre-and post-procedure collaboration

Valvular and structural interventions

16 May 2024 – From EuroPCR 2024

This session features presentations and discussions on various novel transcatheter technologies for valvular and structural heart interventions. It includes a novel transcatheter tricuspid repair technology, a new endovascular aortic root and total arch stent-graft replacement system, a novel self-expandable transcatheter aortic valve, and a transcatheter mitral...

Valvular and structural interventions

TAVI in challenging anatomies

14 May 2024 – From EuroPCR 2024

Explore the complexities of TAVI in patients with intricate aortic stenosis: learn the critical role of detailed CT imaging and meticulous pre-procedural planning, and find out how to customize valve selection and implantation techniques to match unique patient anatomies, such as highly calcified tricuspid valves, low...

TAVI in challenging anatomies

Key questions in aortic valve intervention - What are the surgical and transcatheter treatment options for patients with severe aortic regurgitation?

21 Nov 2023 – From PCR London Valves 2023

Although aortic regurgitation is highly prevalent, it remains under-diagnosed and under-treated. Fortunately, the latest devices should rapidly reverse this trend, both surgically and through transcatheter treatments. Find out more about the options available today, whether surgical or transcatheter, with their benefits and limitations, and how to choose them...

Key questions in aortic valve intervention - What are the surgical and transcatheter treatment options for patients with severe aortic regurgitation?

PCR London Valves 2023 EAPCI Awards Ceremony

21 Nov 2023 – From PCR London Valves 2023

Discover the winners of the EAPCI Awards in this ceremony jointly presented by Emanuele Barbato, EAPCI President, and Tanja Rudolph, Co-Chair of the EAPCI Fellowship Grants Committee. While 14 nominees were shortlisted, seven had already been honored at EuroPCR 2023: Find out who the lucky winners...

EAPCI Awards Ceremony

Mitral valve intervention in complex scenarios - Transcatheter mitral valve replacement - who are the eligible patients, and what are the available options?

21 Nov 2023 – From PCR London Valves 2023

This PCR London Valves 2023 session about mitral valve interventions seeks to address three key questions: identifying the ideal patient for Transcatheter Mitral Valve Implantation (TMVI), exploring treatment alternatives for ineligible patients, and discussing the prediction and management of left ventricular outflow tract obstruction. Watch video...

Mitral valve intervention in complex scenarios - Transcatheter mitral valve replacement - who are the eligible patients, and what are the available options?

Aortic regurgitation - Part 2

21 Nov 2023 – From PCR London Valves 2023

Dive into this session on aortic regurgitation to uncover the promising short-term outcomes of managing aortic regurgitation in patients with LVADs using a specialized TAVI device, to gain insights from an intermodal assessment approach utilizing both cardiac CT and MRI to evaluate the severity of aortic...

Aortic regurgitation - Part 2

Valve performance and durability - Main considerations in selecting the right TAVI valve

20 Nov 2023 – From PCR London Valves 2023

In this session with LIVE case, participants discuss the critical role of valve selection in influencing patient outcomes. The focus includes understanding the latest clinical outcomes of supra-annular TAVI and SAVR, exploring their practical implications. The session also highlights the contribution of novel technology Evolut FX, in...

Valve performance and durability - Main considerations in selecting the right TAVI valve

TAVI: From simple to complex - LIVE case

20 Nov 2023 – From PCR London Valves 2023

This session explores two clinical cases, providing valuable insights into the essential components of a straightforward and efficient TAVI procedure. Find out more about the application of innovative devices to broaden the scope of aortic valve intervention, facilitating their integration into Heart Team discussions and daily...

TAVI - from simple to complex - LIVE case

Mitral edge-to-edge repair using advanced imaging techniques

20 Nov 2023 – From PCR London Valves 2023

Tricuspid valve intervention in complex scenarios - Patient and procedural optimisation

20 Nov 2023 – From PCR London Valves 2023

Watch this session to enhance your knowledge on optimizing patients throughout the entire transcatheter tricuspid valve intervention process— from pre-procedure preparation to post-procedural care. Learn effective strategies for managing immediate and early complications, refine post-procedural treatment plans, and gain insights into future strategies aimed at further...

Tricuspid valve intervention in complex scenarios - Patient and procedural optimisation

Valve-in-valve - LIVE case

17 May 2023 – From EuroPCR 2023

Study the case of a 76-year-old female patient with BMI 32, atrial fibrillation, diabetes, mid chronic kidney disease and history of aortic stenosis, whose Perimount Magna Ease 21 (mismatch) surgical bioprosthesis, implanted in 2016, degenerated, with preserved left ventricular function. 

An Evolut Pro 26 was implanted in...

Valve-in-valve - LIVE case

Clinical outcomes after TAVI: Session 2

29 Nov 2022 – From PCR London Valves 2022

Consult this session on the clinical outcomes after TAVI to learn more about the first results after commercial TAVI utilising the JenaValve Trilogy system for aortic stenosis and aortic regurgitation, the outcomes of contrast-zero TAVI vs. standard practice in patients with severe renal dysfunction, and more!

Clinical outcomes after TAVI: Session 2

Treatment of multi-valve disease

29 Nov 2022 – From PCR London Valves 2022

Get a look at these presentations to learn more about the basic haemodynamic interactions between different valve lesions, the existing surgical standards (and evolving transcatheter standards) for the treatment of multi-valve disease, and to discover a selection of cases that demonstrate the importance of clear indications and appropriate timing...

Treatment of multi-valve disease

Challenging scenarios: acute coronary obstruction

28 Nov 2022 – From PCR London Valves 2022

Discover some challenging case of acute coronary obstruction in these presentations, and learn more about the anatomical and procedural factors that predict this complication during TAVI, the available strategies for coronary protection during TAVI, as well as the leaflet laceration techniques to prevent TAVI-induced coronary obstruction.

Challenging scenarios: acute coronary obstruction

Challenging scenarios: bioprosthetic valve dysfunction

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about the different causes of bioprosthetic valve dysfunction and the best options (surgical, transcatheter or medical) for the management of patients with this kind of dysfunction, as well as to discover how valve design impacts on durability and what the future holds...

Challenging scenarios: bioprosthetic valve dysfunction

The unmet need in severe aortic regurgitation: are we ready for TAVI?

The prevalence of valvular heart disease increases with advanced age and unfortunately, in many patients, it’s underdiagnosed, especially aortic regurgitation. In this presentation recorded for PCR London Valves 2022, Tanja Rudolph raises the question: are we ready for TAVR in aortic regurgitation?

View more videos and course...

The unmet need in severe aortic regurgitation: are we ready for TAVI?

A new evolution: TAVR for aortic regurgitation with the JenaValve Trilogy System

22 Nov 2021 – From PCR London Valves

Watch this session released during PCR London Valves 2021 Congress to have a deep dive into aortic regurgitation: the natural history, the clinical reality of it, and a fantastic live recorded case, so as to gain deeper understanding of the progression of severe aortic regurgitation, to learn more...

A new evolution: TAVR for aortic regurgitation with the JenaValve Trilogy System

Procedural aspects of TAVI patient long-term management

22 Nov 2021 – From PCR London Valves 2021

At the PCR London Valves 2021 Congress, a session was proposed to discuss long-term management of TAVI patients: gain knowledge in procedural PCI access after TAVI through case examples, and learn more about the essential steps of the cusp overlap implantation technique by watching it now!

Procedural aspects of TAVI patient long-term management

Discover the new Evolut­™ PRO+ TAVI System

17 Jun 2021

New data from Optimize PRO interim analysis

From a design built on a proven platform1, the Evolut™ PRO+ system provides the performance and outcomes you need to help patients live life to the fullest.